GLTO
Price
$2.99
Change
-$0.01 (-0.33%)
Updated
May 2 closing price
Capitalization
3.95M
VIVS
Price
$2.00
Change
+$0.03 (+1.52%)
Updated
May 2 closing price
Capitalization
3.6M
18 days until earnings call
Ad is loading...

GLTO vs VIVS

Header iconGLTO vs VIVS Comparison
Open Charts GLTO vs VIVSBanner chart's image
Galecto
Price$2.99
Change-$0.01 (-0.33%)
Volume$16.81K
Capitalization3.95M
VivoSim Lab
Price$2.00
Change+$0.03 (+1.52%)
Volume$171.94K
Capitalization3.6M
GLTO vs VIVS Comparison Chart
Loading...
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLTO vs. VIVS commentary
May 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLTO is a Hold and VIVS is a Hold.

Ad is loading...
COMPARISON
Comparison
May 04, 2025
Stock price -- (GLTO: $2.99 vs. VIVS: $2.00)
Brand notoriety: GLTO and VIVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLTO: 5% vs. VIVS: 9%
Market capitalization -- GLTO: $3.95M vs. VIVS: $3.6M
GLTO [@Biotechnology] is valued at $3.95M. VIVS’s [@Biotechnology] market capitalization is $3.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLTO’s FA Score shows that 1 FA rating(s) are green whileVIVS’s FA Score has 0 green FA rating(s).

  • GLTO’s FA Score: 1 green, 4 red.
  • VIVS’s FA Score: 0 green, 5 red.
According to our system of comparison, both GLTO and VIVS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLTO’s TA Score shows that 3 TA indicator(s) are bullish while VIVS’s TA Score has 3 bullish TA indicator(s).

  • GLTO’s TA Score: 3 bullish, 5 bearish.
  • VIVS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, VIVS is a better buy in the short-term than GLTO.

Price Growth

GLTO (@Biotechnology) experienced а +3.10% price change this week, while VIVS (@Biotechnology) price change was +7.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

Reported Earning Dates

GLTO is expected to report earnings on Mar 19, 2025.

VIVS is expected to report earnings on May 22, 2025.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLTO($3.95M) has a higher market cap than VIVS($3.6M). VIVS YTD gains are higher at: 334.877 vs. GLTO (-35.699).
GLTOVIVSGLTO / VIVS
Capitalization3.95M3.6M110%
EBITDA-19.68MN/A-
Gain YTD-35.699334.877-11%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash19.7MN/A-
Total Debt32KN/A-
FUNDAMENTALS RATINGS
VIVS: Fundamental Ratings
VIVS
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLTOVIVS
RSI
ODDS (%)
N/A
Bearish Trend 6 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend about 1 month ago
88%
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WWD193.923.43
+1.80%
Woodward
INTR6.560.07
+1.08%
Inter & Co
SNPX2.42-0.04
-1.63%
Synaptogenix
IFRX1.73-0.12
-6.49%
InflaRx NV
SES0.81-0.08
-9.49%
SES AI Corp

GLTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLTO has been loosely correlated with XERS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if GLTO jumps, then XERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLTO
1D Price
Change %
GLTO100%
-0.33%
XERS - GLTO
41%
Loosely correlated
+5.13%
VIVS - GLTO
38%
Loosely correlated
+1.52%
SYRE - GLTO
37%
Loosely correlated
+3.07%
RCKT - GLTO
36%
Loosely correlated
+1.91%
RGNX - GLTO
35%
Loosely correlated
+5.80%
More

VIVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIVS has been loosely correlated with GLTO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if VIVS jumps, then GLTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIVS
1D Price
Change %
VIVS100%
+1.52%
GLTO - VIVS
38%
Loosely correlated
-0.33%
ORMP - VIVS
37%
Loosely correlated
+2.20%
ACET - VIVS
27%
Poorly correlated
+6.60%
KRRO - VIVS
26%
Poorly correlated
+13.81%
SLNO - VIVS
26%
Poorly correlated
+0.28%
More